CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.
Hanauer JDS, Rengstl B, Kleinlützum D, Reul J, Pfeiffer A, Friedel T, Schneider IC, Newrzela S, Hansmann ML, Buchholz CJ, Muik A.
Hanauer JDS, et al. Among authors: kleinlutzum d.
Oncotarget. 2018 Jan 12;9(16):12971-12981. doi: 10.18632/oncotarget.24191. eCollection 2018 Feb 27.
Oncotarget. 2018.
PMID: 29560124
Free PMC article.